Novel Foods approval sought for nutritive sweetener

By Shane Starling

- Last updated on GMT

Alberta, Canada-based Bioneutra has applied to the UK Food Standards Agency (FSA) for European Union Novel Foods approval for a prebiotic, isomalto-oligosaccharide sweetener.

Bioneutra’s application indicates it will use powder and syrup forms of isomalto-oligosaccharide as a nutritive sweetener and prebiotic in beverages, cereal products and sugar confectionery as well as nutritionally complete and fortified meal replacement bars and meals.

According to the FSA website, isomalto-oligosaccharide is “a mixture of linked glucose molecules known as oligomers and simple sugars known as oligosaccharides.”

The application will be assessed by the FSA’s Advisory Committee on Novel Foods and Processes, and given typical Novel Foods timelines, may take several years before a verdict is reached.

EU Novel Foods approval is required for foods and ingredients not on-market before May, 1997, and which cannot demonstrate a safe history either inside (15 years) or outside (30 years) Europe.

The EU Novel Foods process has been much criticised for being too laborious and therefore acting as a break on innovation and trade within the EU. Recognising this fact, the European Commission (EC) has mooted that the process may be streamlined but as yet no changes have been put in place.

Suggested revisions include sending applications straight to the European Food Safety Authority (EFSA) after they have been approved by a member state rather than then being sent to each member state for individual opinions – a process that typically drags on for a year or more.

Bioneutra specialises in manufacturing proprietary versions of isomalto-oligosaccharides called VitaSugar derived from wheat, barley and potato and which contain one quarter the calories of regular table sugar.

In 2007 the company was named Emerging Company of the Year by the Agriculture and Food Council of Alberta at its annual award ceremony.

Related news

Related products

show more

Explore the scientific foundations of Nextida™ GC

Explore the scientific foundations of Nextida™ GC

Content provided by Rousselot | 01-Nov-2024 | White Paper

The first commercialised ingredient in the Nextida platform, a range of specific collagen peptide compositions with targeted health benefits, Nextida™...

BB536 for optimal Gut health and beyond

BB536 for optimal Gut health and beyond

Content provided by Morinaga Milk Industry Co., Ltd. | 03-Oct-2024 | White Paper

Among the various probiotics strains available, Bifidobacterium longum BB536 stands out due to its well-documented safety, efficacy, and regulatory approvals....

Unlock sensory innovation with AromatiQ™ technology

Unlock sensory innovation with AromatiQ™ technology

Content provided by Lonza | 20-Sep-2024 | Product Brochure

With 70% of consumers willing to pay a premium for a more enjoyable and memorable supplement experience, Lonza’s new AromatiQ™ technology enables brands...

Related suppliers

Follow us

Products

View more

Webinars